Insulet Corp. Stock
Price
Target price
€210.70
€210.70
-2.190%
-4.7
-2.190%
€216.95
26.09.24 / Tradegate
WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insulet Corp. Stock
A loss of -2.190% shows a downward development for Insulet Corp..
Insulet Corp. is currently one of the favorites of our community with 17 Buy predictions and no Sell predictions.
With a target price of 216 € there is a slightly positive potential of 2.52% for Insulet Corp. compared to the current price of 210.7 €.
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insulet Corp. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -2.190% | -0.613% | 22.393% | 36.863% | 6.173% | -14.593% | 40.635% |
| Neogen Corp. | 1.340% | -1.974% | 1.361% | - | - | - | - |
| Bio-Rad Labs Inc. A | 1.010% | 0.541% | 5.579% | -10.888% | 1.192% | -54.985% | -4.684% |
| Merit Medical Systems | - | -2.247% | 3.571% | 34.884% | 27.941% | 42.623% | 203.877% |
Comments
Insulet Co. (NASDAQ: PODD) had its price target raised by analysts at Piper Sandler from $230.00 to $285.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) had its price target lowered by analysts at BTIG Research from $270.00 to $250.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet Co. (NASDAQ: PODD) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $235.00 price target on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Why Insulet Stock Was Zooming Higher This Week
Specialty device maker Insulet (NASDAQ: PODD) had some good news to impart to the world early this week, and investors jumped on the stock as a result. As the market started to prepare for its
